AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AVECHO BIOTECHNOLOGY LTD

0.023

+0.0029.52%

Volume:9.09M

Turnover:203.37K

Market Cap:88.87M

PE:-16.43

High:0.023

Open:0.021

Low:0.021

Close:0.021

52wk High:0.027

52wk Low:0.005

Shares:3.86B

Float Shares:1.90B

Volume Ratio:3.05

T/O Rate:0.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.001

EPS(LYR):-0.001

ROE:-268.21%

ROA:-25.82%

PB:46.59

PE(LYR):-16.43

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Avecho Biotechnology Ltd-Avecho Strengthens Bd Capability with Senior Appointment

THOMSON REUTERS

Avecho Biotechnology Says Japanese Patent Granted for CBD Capsule

Avecho Biotechnology Ltd-Japanese Patent Granted for Cbd Capsule

THOMSON REUTERS

Avecho to Continue With Full Enrollment in Insomnia Trial After Positive Data Monitoring Board Recommendation; Shares Hit 5.5-Year High

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigermarketb.com/stock/AVE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"AVE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVE.AU\",,,,,undefined,":{"symbol":"AVE.AU","market":"AU","secType":"STK","nameCN":"AVECHO BIOTECHNOLOGY LTD","latestPrice":0.023,"timestamp":1787724720000,"preClose":0.021,"halted":0,"volume":9088944,"delay":0,"changeRate":0.09523809523809515,"nameEN":"AVECHO BIOTECHNOLOGY LTD","floatShares":1896395886,"shares":3863725873,"eps":-0.0014,"marketStatus":"Not Yet Opened","change":0.002,"latestTime":"08-26 16:12:00 AEST","open":0.021,"high":0.023,"low":0.021,"amount":203368,"amplitude":0.095238,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0014,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.021,"openAndCloseTimeList":[[1787702400000,1787724000000]],"volumeRatio":3.0530026560216976,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"AVE.AU","preClose":0.023,"auctionPrice":0.023,"auctionVolume":3841,"auctionTime":1787780225942,"referenceTime":1787740203093,"auction":1,"marketStatus":"盘前竞价","timestamp":1787780225942}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVE.AU\",,,,,undefined,":{"symbol":"AVE.AU","floatShares":1896395886,"roa":"-25.82%","roe":"-268.21%","lyrEps":-0.0014,"volumeRatio":3.0530026560216976,"shares":3863725873,"dividePrice":0,"high":0.023,"amplitude":0.095238,"preClose":0.021,"low":0.021,"week52Low":0.005,"pbRate":"46.59","psRate":"120.53","week52High":0.027,"institutionHeld":0,"latestPrice":0.023,"eps":-0.0014,"divideRate":0,"volume":9088944,"delay":0,"ttmEps":-0.0014,"open":0.021,"prevYearClose":0.009,"prevWeekClose":0.021,"prevMonthClose":0.019,"prevQuarterClose":0.024,"fiveDayClose":0.019,"twentyDayClose":0.02,"sixtyDayClose":0.012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661490192","title":"Avecho Biotechnology Ltd-Avecho Strengthens Bd Capability with Senior Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2661490192","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661490192?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:54","pubTimestamp":1787529266,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nTUE5QWC6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","AVE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656346629","title":"Avecho Biotechnology Says Japanese Patent Granted for CBD Capsule","url":"https://stock-news.laohu8.com/highlight/detail?id=2656346629","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656346629?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:49","pubTimestamp":1785714569,"startTime":"0","endTime":"0","summary":"BRIEF-Avecho Biotechnology Says Japanese Patent Granted For CBD CapsuleAug 3 (Reuters)-Avecho Biotechnology LtdAVE.AX:JAPANESE PATENT GRANTED FOR CBD CAPSULEFurther company coverage:AVE.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260802:nTUE7DBFNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","AVE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656648346","title":"Avecho Biotechnology Ltd-Japanese Patent Granted for Cbd Capsule","url":"https://stock-news.laohu8.com/highlight/detail?id=2656648346","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656648346?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:48","pubTimestamp":1785714504,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260802:nTUE7DBFNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVE.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645863328","title":"Avecho to Continue With Full Enrollment in Insomnia Trial After Positive Data Monitoring Board Recommendation; Shares Hit 5.5-Year High","url":"https://stock-news.laohu8.com/highlight/detail?id=2645863328","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645863328?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:20","pubTimestamp":1782264025,"startTime":"0","endTime":"0","summary":"Avecho Biotechnology  said an independent data monitoring board recommended that the company's phase 3 clinical trial evaluating TPM-enhanced cannabidiol capsule for insomnia continue to the full planned enrolment of 519 participants, according to a Wednesday filing with the Australian bourse.The data monitoring board issued the recommendation following an interim analysis that showed no serious adverse events across 244 initial participants.\"The interim analysis represents a major value-inflection point for the program, reducing clinical development risk and providing a defined pathway toward completion of the pivotal study,\" the company said.Avecho added that it has already identified additional clinical sites to speed up the recruitment of the second patient cohort.The company's shares gained 33% in recent Wednesday activity and earlier hit their highest since December 2020.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVE.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AVE.AU\",params:#limit:6,delay:true,,,undefined,":[]}}